Reliability of stroke diagnosis in emergency departments;Fiabilidad del diagnóstico de ictus en urgencias

Neurologia

Volumn 27, Issue 5, 2012, Pages 284-289

  Martinez Fernandez E ^a   Sanz Fernandez G ^a   Blanco Ollero, A ^a  

^a HOSPITAL JUAN RAMÓN JIMÉNEZ   (Spain)

Author keywords

Andalusia; Neurologist; PASI; Stroke; Stroke teams; Stroke units; Thrombolysis

Indexed keywords

ARTICLE; BLOOD CLOT LYSIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; EMERGENCY WARD; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PHYSICIAN; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; STROKE;

EMERGENCY SERVICE, HOSPITAL; HUMANS; REPRODUCIBILITY OF RESULTS; STROKE;

EID: 84861478567     PISSN: 02134853     EISSN: 15781968     Source Type: Journal    
DOI: 10.1016/j.nrl.2011.12.006     Document Type: Article

References (21)

1. Del Zoppo G.J., Saver J.L., Jauch E.C., Adams H.P. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke 2009, 40:2945-2948. American Heart Association Stroke Council.
2. Executive Committee and the ESO Writing Committee. Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008. Cerebrovasc Dis 2008, 25:457-507. The European Stroke Organisation (ESO).
3. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995, 333:1581-1587. The National Institute of Neurological Disorders, Stroke, rt-PA, stroke study group.
4. Katzan I.L., Firlan A.J., Lloyd L.E., Frank J.I., Harper D.L., Hinchey J.A., et al. Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. JAMA 2000, 283:1151-1158.
5. Wahlgren N., Ahmed N., Eriksson N., Aichner F., Bluhmki E., Dávalos A., et al. Safe Implementation of Thrombolysis in Stroke-Monitoring Study Investigators. Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST). Stroke 2008, 39:3316-3322.
6. Alvarez-Sabín J., Alonso de Leciñana M., Gallego J., Gil-Peralta A., Casado I., Castillo J., et al. Plan de atención sanitaria al ictus (PASI). Neurología 2006, 21:717-726.
7. Masjuan J., álvarez-Sabin J., Arenillas J., Calleja S., Castillo J., Dávalos A., et al. Plan de asistencia sanitaria al ICTUS II 2010. Neurología 2011, 26:383-396.
8. Estrategia en ictus del Sistema Nacional de Salud. Estrategia aprobada por el Consejo Interterritorial del Sistema Nacional de Salud el 26 de noviembre de 2008. Coordinador científico: Matías-Guiu J.
9. Plan andaluz de atención al ictus 2011-2014. Coordinación y autoría: Jiménez Hernández MD, Alcázar Romero PP, Alés Otón E, Aranda Aguilar F, Arraez Sánchez MA, Carrillo Badillo E, et al. Sevilla:CConsejería de Salud, 2011. Junta de Andalucía. Consejería de Salud; 2011.
10. Wang D.Z., Rose J.A., Honings D.S., Garwacki D.J., Milbrandt J.C. Treating acute stroke patients with intravenous tPA:the OSF Stroke Network experience. Stroke 2000, 31:77-81.
11. Tanne D., Bates V.E., Verro P., Kasner S.E., Binder J.R., Patel S.C., et al. Initial clinical experience with IV tissue plasminogen activator for acute ischemic stroke: a multicenter survey. Neurology 1999, 53:424-427. for the tPA Stroke Survey Group.
12. Albers GW, Bates VE, Clark WM, Bell R, Verro P, Hamilton SA. Intravenous tissue-type plasminogen activator for treatment of acute stroke. The standard treatment with alteplase to reverse stroke (STARS) study. JAMA. 2000;283:1145-50.
13. Bravata D.M., Kim N., Concato J., Krumholz H.M., Brass L.M. Thrombolysis for acute stroke in routine clinical practice. Arch Intern Med 2002, 162:1994-2001.
14. Reed S.D., Cramer S.C., Blough D.K., Meyer K., Jarvik J.G. Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals. Stroke 2001, 32:1832-1840.
15. Heuschmann P.U., Kolominsky-Rabas P.L., Roether J., Misselwitz B., Lowitzsch K., Heidrich J., et al. German Stroke Registers Study Group. Predictors of in-hospital mortality in patients with acute ischemic stroke treated with trombolytic therapy. J Am Med Assoc 2004, 292:1831-1838.
16. Demchuck A.M., Tanne D., Hill M.D., Kasner S.E., Hanson S., Grond M., et al. Predictors of good outcome after intravenous tPA for acute ischemic stroke. Neurology 2001, 57:474-480.
17. López-Yunez A.M., Bruno A., Zurru C., Williams L.S., Biller J. Protocol violations in community-based rt-PA use are associated with symptomatic intracerebral hemorrhage. Stroke 2001, 32:12-16.
18. Maestre-Moreno J.F., Serrano-Castro P.J., Aguilera-Navarro J.M. Trombólisis en el ictus: la accesibilidad sin garantía de seguridad es insostenible. Rev Calidad Asistencial 2005, 2:409-411.
19. Akins P.T., Delemos C., Wentworth, Byer J., Schorer S.J., Atkinson R.P. Can emergency department physicians safely and effectively initiate thrombolysis for acute ischemic stroke?. Neurology 2000, 55:1801-1805.
20. Asimos A.W., Norton H.J., Price M.F., Cheek W.M. Therapeutic yield and outcomes of a community teaching hospital code stroke protocol. Acad Energ Med 2004, 11:361-370.
21. Gillum L.A., Johnston S.C. Characteristics of academic medical centers and ischemic stroke outcome. Stroke 2001, 32:2137-2142.